In this section you will find new and updated content within the MEDVERSATION® web application. To retrieve the full text of any of the topics listed below, please click on one of the color-coded links: Orange - Natural History of Disease, Green - Benefits of Treatments, Blue - Risks of Treatments and Red - Benefit:Risk Analysis.
What's New 1 - 25 of 25
1
- Malignancy – Introduction and Risk In Underlyin .... New 07/07/2010
- Pregnancy and Immune-Mediated Inflammatory Diso .... New 07/07/2010
- Neurologic Events – Overview and Risk in Underl .... New 07/02/2010
- Infections – Overview New 07/02/2010
- Hematologic Events – Overview and Risk in Under .... New 07/02/2010
- Congestive Heart Failure – Overview and Risk in .... New 07/01/2010
- Tuberculosis – Screening, Diagnosis, and Treatment New 07/01/2010
- Pregnancy – Risk and Considerations With Golimu .... New 07/01/2010
- Neurologic Events — Risk With Golimumab Therapy New 07/01/2010
- Malignancy — Risk With Golimumab Therapy New 07/01/2010
- Infections – Risk With Golimumab Therapy New 07/01/2010
- Hepatitis B Virus Reactivation and Other Hepati .... New 07/01/2010
- Ankylosing Spondylitis – Benefits of Golimumab .... New 07/01/2010
- Psoriatic Arthritis – Benefits Of Golimumab The .... New 07/01/2010
- Rheumatoid Arthritis – Benefits of Golimumab Th .... New 07/01/2010
- Administration Reactions – Risk With Golimumab .... New 07/01/2010
- Congestive Heart Failure – Considerations With .... New 07/01/2010
- Hematologic Events – Risk With Golimumab Therapy New 07/01/2010
- Resources and Guidance Documents From the FDA Updated 05/20/2010
- Risk Management Overview Updated 05/20/2010
- Sample Decision Algorithm and Case Example Updated 05/20/2010
- Etiology of Ankylosing Spondylitis Updated 04/01/2010
- Extra-articular Manifestations in Ankylosing Sp .... Updated 04/01/2010
- Psoriatic Arthritis: Economic Burden of Disease .... Updated 01/21/2010
- Benefits of Treatment New 08/19/2009
What's New 1 - 25 of 25
1